G1 Therapeutics Net Profit Margin 2016-2024 | GTHX
G1 Therapeutics net profit margin from 2016 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-06-30 | $0.06B | $-0.04B | -75.86% |
| 2024-03-31 | $0.08B | $-0.03B | -36.14% |
| 2023-12-31 | $0.08B | $-0.05B | -58.54% |
| 2023-09-30 | $0.08B | $-0.07B | -92.21% |
| 2023-06-30 | $0.09B | $-0.08B | -87.64% |
| 2023-03-31 | $0.06B | $-0.13B | -217.24% |
| 2022-12-31 | $0.05B | $-0.15B | -282.69% |
| 2022-09-30 | $0.05B | $-0.15B | -318.75% |
| 2022-06-30 | $0.03B | $-0.17B | -586.21% |
| 2022-03-31 | $0.03B | $-0.17B | -680.00% |
| 2021-12-31 | $0.03B | $-0.15B | -459.38% |
| 2021-09-30 | $0.04B | $-0.13B | -306.98% |
| 2021-06-30 | $0.07B | $-0.10B | -156.92% |
| 2021-03-31 | $0.06B | $-0.09B | -156.67% |
